慢性病患者参与医患共同决策影响因素的Meta分析

doi:10.16460/j.issn1008-9969.2023.20.019

摘要/Abstract

摘要： 目的对慢性病患者参与医患共同决策的影响因素进行Meta分析,为提高慢性病患者共同决策参与率提供科学依据。方法系统检索中国知网、维普、万方、PubMed和Web of Science中英文数据库公开发表的有关慢性病患者参与医患共同决策影响因素的文献,利用Review Manager 5.4和Stata 13.0软件进行效应量合并。结果共检索到700篇文献,根据纳排标准,最终纳入17篇中英文文献。结果显示慢性病患者医患共同决策合并参与率为36.90%（28.80%~45.00%）;年龄（OR=0.92,95%CI：0.82~0.99）、文化程度（OR=1.57,95%CI：1.24~1.99）、家庭人均月收入（OR=1.60,95%CI：1.12~2.28）、是否首次手术（OR=1.85,95%CI：1.27~2.70）、疾病相关知识了解（OR=0.98,95%CI：0.96~0.99）是影响慢性病患者参与共同决策的重要因素。结论慢性病患者医患共同决策参与率有待进一步提高,慢性病患者参与医患共同决策受多种因素影响,应对医患双方采取相应措施来提高共同决策参与率。

关键词: 慢性病, 医患共同决策, 影响因素, Meta分析

Abstract: Objective To analyze the influencing factors of the participation of patients with chronic disease in doctor-patient shared decision-making by meta-analysis, and provide reference for improving the participation of patients with chronic disease in shared decision-making. Methods A systematic search was conducted on literature in Chinese and English databases including CNKI, VIP, Wangfang, PubMed, and Web of Science on the influencing factors of participation of patients with chronic disease in shared decision-making. The effects were merged using Review Manager 5.4 and Stata13.0. Results A total of 700 pieces of literature were retrieved, and 17 pieces of eligible Chinese and English literature were ultimately included. The rate of participation in shared decision-making of patients with chronic disease was 36.90%(28.80%~45.00%). Age (OR=0.92,95%CI:0.82~0.99), educational background (OR=1.57,95%CI: 1.24~1.99), monthly income per capita (OR=1.60,95%CI: 1.12~2.28), whether the first time to perform surgery (OR=1.85,95%CI: 1.27~2.70), and disease- related knowledge (OR=0.98,95%CI: 0.96~0.99) were important factors that affect the participation of patients with chronic disease in shared decision-making. Conclusion The participation rate of patients with chronic disease in doctor-patient shared decision-making needs to be further improved. The participation is influenced by multiple factors, and corresponding measures should be taken by both doctors and patients to increase the participation rate.

Key words: chronic disease, shared decision making, influencing factor, Meta-analysis

中图分类号:

钱怡, 周清平, 梁振宁, 王晨曦, 刘涵月, 于瑶, 玉素扑江·图尔荪, 王冬. 慢性病患者参与医患共同决策影响因素的Meta分析[J]. 护理学报, 2023, 30(20): 19-23.

QIAN Yi, ZHOU Qing-ping, LIANG Zhen-ning, WANG Chen-xi, LIU Han-yue, YU Yao, YUSUPUJIANG·TUERSUN, WANG Dong. Influencing factors of participation in doctor-patient shared decision-making in patients with chronic disease: a Meta-analysis[J]. Journal of Nursing, 2023, 30(20): 19-23.

参考文献

[1] 胡安霞,闫娟娟,裴中阳.山西省慢性病患者住院服务利用现状及影响因素研究[J].现代预防医学,2023,50(3):495-500;516. DOI:10.20043/j.cnki.MPM.202205516.
[2] 胡恒瑜,张亚英,陈羽双,等.患者参与医疗保健及其影响因素的研究进展[J].中华护理杂志,2017,52(6):740-745. DOI:10.3761/j.issn.0254-1769.2017.06.020.
[3] Granados-Santiago M, Valenza MC, López-López L, et al.Shared decision-making and patient engagement program during acute exacerbation of COPD hospitalization: a randomized control trial[J]. Patient Educ Couns, 2020,103(4):702-708. DOI:10.1016/j.pec.2019.12.004.
[4] 黄榕翀,徐鸣悦,郭宏洲.中国医患共同决策现状与挑战[J].中华医学杂志,2020,100(30):2346-2350. DOI:10.3760/cma.j.cn112137-20200606-01789.
[5] 曾宪涛,刘慧,陈曦,等.Meta分析系列之四:观察性研究的质量评价工具[J].中国循证心血管医学杂志,2012,4(4):297-299. DOI:10.3969/j.1674-4055.2012.04.004.
[6] Stang A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010,25(9):603-605. DOI:10.1007/s10654-010-9491-z.
[7] 陈醒. 长沙市某三甲医院中老年2型糖尿病患者医患共同决策现状及其影响因素研究[D].长沙:湖南师范大学,2021. DOI:10.27137/d.cnki.ghusu.2021.002870.
[8] 李玉,叶志霞,刘佩玉,等.原发性肝癌诊断知情患者参与手术决策现状及影响因素研究[J].护理学报,2016,23(18):6-11. DOI:10.16460/j.issn1008-9969.2016.18.006.
[9] 马文翰,白雪霏,陈照娟,等.社区全科门诊慢性病患者参与治疗决策现状及影响因素研究[J].中国全科医学,2022,25(10):1206-1212.DOI:10.12114/j.issn.1007-9572.2021.00.312.
[10] 缪爱云,吴奇云,李丽,等.原发性肝癌患者参与治疗决策现状及影响因素分析[J].护理学报,2015,22(7):5-9. DOI:10.16460/j.issn1008-9969.2015.07.005.
[11] 王佳,刘雨鑫,王若溪,等.武汉市老年慢性病共存患者用药决策参与行为研究[J].医学与社会, 2021, 34(1):46-50. DOI:10.13723/j.yxysh.2021.01.010.
[12] 张金. 医患共同决策在心脑血管疾病门诊治疗过程中的应用及其影响因素研究[D].济南:山东大学,2021. DOI:10.27272/d.cnki.gshdu.2021.004660.
[13] 张振香,刘雪婷,张春慧,等.慢性共病患者用药参与决策行为的潜在类别及其影响因素分析[J].军事护理,2022,39(12):30-33. DOI:10.3969/j.issn.2097-1826.2022.12.008.
[14] 曹洁,孙彩红,丁艳,等.前列腺癌病人手术决策类型及其影响因素[J].护理研究, 2020, 34(11):1878-1881. DOI:10.12102/j.issn.1009-6493.2020.11.002.
[15] 王璐,戴付敏,王飞杰,等.前列腺癌患者共享决策现状及影响因素分析[J].临床研究,2021,29(3):166-168.
[16] 张雅芝,方汉萍,朱利思,等.基于临床决策理论的癌症病人共享决策概念框架的构建[J].护理研究,2020,34(1):136-141. DOI:10.12102/j.issn.1009-6493.2020.01.026.
[17] 张金娜. 肺癌患者参与共享决策现状及影响因素分析[D].青岛:青岛大学,2020.DOI:10.27262/d.cnki.gqdau.2020.000046.
[18] Mah HC, Muthupalaniappen L, Chong WW.Perceived involvement and preferences in shared decision-making among patients with hypertension[J]. Fam Pract,2016,33(3):296-301. DOI:10.1093/fampra/cmw012.
[19] Smith SG, Pandit A, Rush SR, et al.The role of patient activation in preferences for shared decision making: results from a national survey of U.S. adults[J]. J Health Commun, 2016,21(1):67-75. DOI:10.1080/10810730.2015.1033115.
[20] AlHaqwi AI, AlDrees TM, AlRumayyan A, et al. Shared clinical decision making. A Saudi Arabian perspective[J].Saudi Med J, 2015,36(12):1472-1476. DOI:10.15537/smj.2015.12.13682.
[21] Lee KS, Oh O, Miller J, et al.Patients’ openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study[J]. Eur J Cardiovasc Nurs, 2022,21(7):687-693. DOI:10.1093/eurjcn/zvab130.
[22] Morishige R, Nakajima H, Yoshizawa K, et al.Preferences regarding shared decision-making in Japanese inflammatory bowel disease patients[J]. Adv Ther, 2017,33(12):2242-2256.DOI:10.1007/s12325-016-0436-0.
[23] Schellartz I, Ohnhaeuser T, Mettang T, et al.Information about different treatment options and shared decision making in dialysis care-a retrospective survey among hemodialysis patients[J]. BMC Health Serv Res, 2021,21(1):673. DOI:10.1186/s12913-021-06599-7.
[24] Heesen C, Kasper J, Segal J, et al.Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis[J]. Mult Scler,2004,10(6):643-650. DOI:10.1191/1352458504ms1112oa.
[25] Baars JE, Markus T, Kuipers EJ, et al.Patients’ preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study[J]. Digestion, 2010,81(2):113-119.DOI:10.1159/000253862.
[26] 许传先,杜春晓,吴国荣,等.中国儿童青少年高血压患病率及影响因素META分析[J].现代预防医学, 2021,48(23):4276-4280,4311.
[27] 赵国光. 医患共同决策的研究现状及展望[J].中国医院管理,2020,40(1):59-62.
[28] 李福明,滕悦,刘柳,等.医患共同决策在中医药技术抗肿瘤过程中的应用分析[J].中国医院管理,2022,42(8):16-19.
[29] 胡婵,左丙丽,王沙沙,等.癌症患者参与医患共同决策影响因素的Meta分析[J].中华肿瘤防治杂志,2022,29(3):217-222. DOI:10.16073/j.cnki.cjcpt.2022.03.11.
[30] 肖霖,彭美芳,刘亚玮,等.癌症患者参与能力对其感知医患共同决策水平的影响[J].护理学杂志,2022,37(20):42-45. DOI:10.3870/j.issn.1001-4152.2022.20.042.
[31] 翁冰冰,陈文,蒋虹丽.医患共同决策模型及实践应用进展[J].医学与哲学, 2023, 44(5):21-25.DOI:10.12014/j.issn.1002-0772.2023.05.05.
[32] 何清新,夏文芳.医患共同决策面临的问题及解决方法探索[J].医学与哲学,2023,44(5):18-20;67. DOI:10.12014/j.issn.1002-0772.2023.05.04.

Metrics

Viewed

Full text

Abstract

Cited

Shared